MedPath

A study to identify the frequency and characteristics of patients with a bispectral index value of 60 or higher during induction and maintenance of general anesthesia with remimazolam

Not Applicable
Conditions
Neoplasms
Registration Number
KCT0007101
Lead Sponsor
Asan Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
1500
Inclusion Criteria

1. Patients who underwent general anesthesia in the operating rooms of Asan Medical Center from October 2021 to January 2022
2. Patients who underwent general anesthesia with remimazolam confirmed by dosing records on anesthesia record sheets

Exclusion Criteria

1. Patients with anesthesia induction and maintenance with propofol or sevoflurane
2. Patients whose reasons for changing the hypnotic agent during induction and maintenance of anesthesia are not recorded on the anesthesia record sheet

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of patients with a bispectral index value of 60 or higher during general anesthesia with remimazolam
Secondary Outcome Measures
NameTimeMethod
Whether there is a difference in physical characteristics between patients with well-maintained bispectral index below 60 and those who do not
© Copyright 2025. All Rights Reserved by MedPath